Found: 7
Select item for more details and to access through your institution.
Intravenous Immunoglobulin Therapy for Critically Ill COVID-19 Patients With Different Inflammatory Phenotypes: A Multicenter, Retrospective Study.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2021.738532
- By:
- Publication type:
- Article
One-year follow-up study after patients with severe COVID-19 received human umbilical cord mesenchymal stem cells treatment.
- Published in:
- Stem Cell Research & Therapy, 2022, v. 13, n. 1, p. 1, doi. 10.1186/s13287-022-02972-3
- By:
- Publication type:
- Article
Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study.
- Published in:
- Intensive Care Medicine, 2020, v. 46, n. 10, p. 1863, doi. 10.1007/s00134-020-06211-2
- By:
- Publication type:
- Article
Baidu Jieduan granules, traditional Chinese medicine, in the treatment of moderate coronavirus disease-2019 (COVID-19): study protocol for an open-label, randomized controlled clinical trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Polyethylene glycol‐based ultrasonic‐assisted enzymatic extraction, characterization, and antioxidant activity in vitro and in vivo of polysaccharides from Lonicerae japonica leaves.
- Published in:
- Food Science & Nutrition, 2019, v. 7, n. 11, p. 3452, doi. 10.1002/fsn3.1186
- By:
- Publication type:
- Article
Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells.
- Published in:
- Stem Cell Research & Therapy, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13287-020-01875-5
- By:
- Publication type:
- Article
Shenhuang granule in the treatment of severe coronavirus disease 2019 (COVID-19): study protocol for an open-label randomized controlled clinical trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article